Dynatronics Corporation

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Dynatronics Corporation - overview

Established

1979

Location

Salt Lake City, UT, US

Primary Industry

Medical Devices & Equipment

About

Dynatronics Corporation is focused on developing and manufacturing advanced therapeutic equipment, offering innovative solutions in electrotherapy and light therapy for healthcare providers. Founded in 1979 in Salt Lake City, US, Dynatronics Corporation specializes in therapeutic equipment development. The company's latest funding round was a PIPE in December 2016, raising USD 0. 98 mn from Prettybrook Partners.


Dynatronics has successfully executed 2 deals, maintaining a consistent focus on therapeutic innovation. Dynatronics Corporation specializes in the development and manufacturing of advanced therapeutic equipment, with a primary focus on electrotherapy and light therapy modalities. Their flagship product, the Solaris Plus, integrates electrotherapy, TriWave Light, and ultrasound capabilities, offering comprehensive treatment solutions for clinics, hospitals, and athletic training facilities. The devices address clinical needs such as pain reduction, functional improvement, and soft tissue mobilization, enhancing traditional treatment protocols.


The company serves a range of healthcare providers, including physical therapists, athletic trainers, and rehabilitation centers, particularly in North America and select international markets. In the most recent year, Dynatronics reported revenue of USD 32. 53 mn, with an EBITDA of USD -0. 82 mn.


The company generates revenue through direct sales of therapeutic products to healthcare facilities, engaging in business-to-business transactions to support patient care; pricing strategies reflect a competitive approach within the industry and a commitment to enhancing therapeutic outcomes. Dynatronics plans to utilize the funds raised in the recent PIPE round to support upcoming product launches and market expansions. The company is designing new therapeutic solutions aimed at enhancing its existing product line, with plans for release in 2024. Furthermore, Dynatronics is targeting growth in both domestic and select international markets, building on its established presence since 1979, as it continues to expand its reach in providing advanced therapeutic equipment.


Current Investors

Prettybrook Partners

Primary Industry

Medical Devices & Equipment

Sub Industries

Therapeutic Devices

Website

www.dynatronics.com

Company Stage

Mature - Growth Capital

Total Amount Raised

Subscriber access only

Dynatronics Corporation - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-onCompletedHausmann Industries, Inc.-
PIPECompletedDynatronics Corporation-
PIPECompletedDynatronics Corporation-

Displaying 1 - 3 of 3

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.